Danone has announced a recall of specific batches of its infant formula products in selected markets following recent updates from local food safety authorities. The recall affects a limited number of production runs manufactured in Ireland and distributed to Europe and the Middle East. Danone emphasizes that all routine quality controls and additional targeted analyses confirm its formulas meet or exceed applicable safety regulations. The decision to withdraw these batches was taken proactively to align with the latest official recommendations and ensure continued consumer confidence in the brand’s specialized nutrition portfolio.

A recent CoBank report highlights robust growth in consumer demand for high-protein foods, with seven in 10 Americans seeking increased protein intake by 2025. Danone’s Oikos Greek yogurt business has delivered double-digit growth in its high-protein lines, attributed in part to rising use of GLP-1 weight-loss medications that steer users toward protein-rich diets. Ready-to-drink protein shake sales have surged 71% over four years to $8.1 billion, underscoring the value of dairy-based ingredients. Danone is leveraging its global R&D network to expand dairy-derived protein solutions for snacks, baked goods and beverages, aiming to capture premium margins of up to 12% on high-protein claims.